{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T08:59:46Z","timestamp":1777021186773,"version":"3.51.4"},"reference-count":49,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2019,5,12]],"date-time":"2019-05-12T00:00:00Z","timestamp":1557619200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clinical Transplantation"],"published-print":{"date-parts":[[2019,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>These updated guidelines from the Infectious Diseases Community of Practice of the American Society of Transplantation review the diagnosis, prevention, and management of Human T\u2010cell lymphotrophic virus 1 (HTLV)\u20101 in the pre\u2010 and post\u2010transplant period. HTLV\u20101 is an oncogenic human retrovirus rare in North America but endemic in the Caribbean and parts of Africa, South America, Asia, and Oceania. While most infected persons do not develop disease, &lt;5% will develop adult T\u2010cell leukemia\/lymphoma or neurological disease. No proven antiviral treatment for established HTLV\u20101 infection is available. The effect of immunosuppression on the development of HTLV\u20101\u2010associated disease in asymptomatically infected recipients is not well characterized, and HTLV\u20101\u2010infected individuals should be counseled that immunosuppression may increase the risk of developing HTLV\u20101\u2010associated disease and they should be monitored post\u2010transplant for HTLV\u20101\u2010associated disease. Currently approved screening assays do not distinguish between HTLV\u20101 and HTLV\u20102, and routine screening of deceased donors without risk factors in low seroprevalence areas is likely to result in significant organ wastage and is not recommended. Targeted screening of donors with risk factors for HTLV\u20101 infection and of living donors (as time is available to perform confirmatory tests) is reasonable.<\/jats:p>","DOI":"10.1111\/ctr.13575","type":"journal-article","created":{"date-parts":[[2019,4,25]],"date-time":"2019-04-25T15:44:09Z","timestamp":1556207049000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Human T\u2010cell lymphotrophic virus in solid\u2010organ transplant recipients: Guidelines from the American society of transplantation infectious diseases community of practice"],"prefix":"10.1111","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0990-4148","authenticated-orcid":false,"given":"Daniel R.","family":"Kaul","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Division of Infectious Diseases University of Michigan Medical School Ann Arbor Michigan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanvi S.","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Infectious Diseases Boston Children\u2019s Hospital, Harvard Medical School Boston Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the AST ID Community of Practice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2019,5,12]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.patbio.2008.02.015"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.01425"},{"issue":"3","key":"e_1_2_10_4_1","first-page":"144","article-title":"The epidemiology and disease outcomes of human T\u2010lymphotropic virus type II","volume":"6","author":"Murphy E","year":"2004","journal-title":"AIDS Rev"},{"issue":"11","key":"e_1_2_10_5_1","first-page":"1102","article-title":"A study of HTLV\u2010I and its associated risk factors in Trinidad and Tobago","volume":"3","author":"Blattner WA","year":"1990","journal-title":"J Acquir Immune Defic Syndr"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1208968"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.284.2.229"},{"issue":"1","key":"e_1_2_10_8_1","first-page":"189","article-title":"Human T lymphotropic virus 1\u20132 positive antibodies in potential organ donors in France","volume":"28","author":"Claquin J","year":"1996","journal-title":"Transpl Proc"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2009.02867.x"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13141"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piu070"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910510609"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00021-07"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1827.2007.02207.x"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis273"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2005.03.132"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-1345(98)00980-4"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2011.11.021"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0215(200002)9999:9999<::AID-IJC1125>3.0.CO;2-N"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2012.04037.x"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e31819ebf76"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-6143.2002.20712.x"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-1345(98)00261-9"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2000.40111421.x"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2008.12.050"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2015.09.010"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2016-215243"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13365-018-0627-3"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.54.2950"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12849"},{"key":"e_1_2_10_31_1","first-page":"4203079","article-title":"Two cases of human T\u2010lymphotropic virus Type I\u2010associated myelopathy\/tropical spastic paraparesis caused by living\u2010donor renal transplantation","volume":"2016","author":"Tajima Y","year":"2016","journal-title":"Case Rep Neurol Med"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1809779"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2004.05.016"},{"key":"e_1_2_10_34_1","unstructured":"Package insert: Abbott HTLV\u2010I\/HTLV\u2010II EIA."},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00315691"},{"issue":"3","key":"e_1_2_10_36_1","first-page":"161","article-title":"Prospects for the management of human T\u2010cell lymphotropic virus type 1\u2010associated myelopathy","volume":"13","author":"Martin F","year":"2011","journal-title":"AIDS Rev"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.43.10.2125"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4690-3-63"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr404"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3181ffb9bb"},{"key":"e_1_2_10_41_1","unstructured":"Food and Drug Administration.2012;www.fda.gov\/BiologicsBloodVaccines\/BloodBloodProducts\/ApprovedProducts\/licensedProductsBLAs\/BloodDonorScreening\/InfectiousDisease\/ucm090707.htm."},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.22087"},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.1086\/510679"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00063-09"},{"issue":"8","key":"e_1_2_10_45_1","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1182\/blood.V76.8.1657.1657","article-title":"Transmission of HTLV\u2010I by blood transfusion and its prevention by passive immunization in rabbits","volume":"76","author":"Kataoka R","year":"1990","journal-title":"Blood"},{"key":"e_1_2_10_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2005.12.002"},{"key":"e_1_2_10_47_1","unstructured":"AminRM JonesB RubertM et al.Risk of retroviral infection among retrovirology laboratory and health care workers. American society for Microbiology 92nd general meeting New Orleans Louisiana May 26\u201330 1992. {abstract T\u201020}."},{"key":"e_1_2_10_48_1","unstructured":"Electronic Therapeutic Guidelines.http:\/\/www.tg.org.au\/etg_demo\/tgc\/abg\/4651.htm#4703ID_GL."},{"key":"e_1_2_10_49_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01413-10"},{"key":"e_1_2_10_50_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-07-230912"}],"container-title":["Clinical Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ctr.13575","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ctr.13575","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ctr.13575","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T07:17:45Z","timestamp":1694243865000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ctr.13575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,12]]},"references-count":49,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["10.1111\/ctr.13575"],"URL":"https:\/\/doi.org\/10.1111\/ctr.13575","archive":["Portico"],"relation":{},"ISSN":["0902-0063","1399-0012"],"issn-type":[{"value":"0902-0063","type":"print"},{"value":"1399-0012","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,12]]},"assertion":[{"value":"2019-03-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-04-18","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e13575"}}